bioRxiv Science⌕ Search

Biology subjects

Angebault, C.

Publications and source records attributed to Angebault, C..

2 recordsLinked to original sources

Performance of shotgun metagenomic sequencing for detection of fungi and parasites across clinical sample types: a multicenter retrospective study.

To evaluate the diagnostic performance of clinical shotgun metagenomic sequencing (SMg) for detecting medically relevant fungi and parasites compared with standard of care (SoC), and to define read-based thresholds for interpretation, we retrospectively analyzed 198 clinical samples from 187 patients across four university hospitals (2018-2022): blood (n=37), faeces (n=63), respiratory fluids (n=54), other biological fluids (n=24), and tissue biopsies (n=20). Total nucleic acids were sequenced ([&ge;]10 million reads per library) and processed with MetaMIC v2.2.1. Data were normalized as reads per million (RPM). Receiver operating characteristic analyses were used to derive optimal RPM thresholds by sample type. SoC identified microorganisms in 152/198 samples (76.8%). All 46 SoC-negative samples were also negative by SMg. At the genus level, SoC identified 187 taxa and SMg 175. Of these, 147 (78.6%) were detected by both methods, 40 (21.4%) by SoC only, and 28 (14.9%) by SMg only. The overall genus-level F1-score was 0.84. Quantification cycle (Cq) values (n=57) correlated inversely with RPM (p<0.001), and no false negatives occurred with Cq<28.6. Optimal thresholds were 0.06 RPM for faeces (AUC 0.89), 0.07 for respiratory fluids (AUC 0.93; sensitivity 88.9%, specificity 90.7%), 0.09 for blood (AUC 0.99), 0.19 for other fluids (AUC 0.94), and 0.57 for biopsies (AUC 0.89). A global threshold of 0.06 RPM yielded an AUC of 0.92 (sensitivity 88.9%, specificity 88.5%). A pragmatic uniform 0.1 RPM threshold maintained performance, while sample-type specific thresholds further improved accuracy, supporting standardized implementation of clinical metagenomics for fungal and parasitic diagnostics.

microbiology↗

LIX1 controls digestive mesenchyme-derived cell fate decision by regulating cristae organization in mitochondria

Limb Expression 1 (LIX1) is a master regulator of digestive mesenchymal progenitor and GastroIntestinal Stromal Tumor (GIST) cell proliferation by controlling the expression of the Hippo effectors YAP1/TAZ and KIT. However, the underlying mechanisms of these LIX1-mediated regulations and tumor promotion remain to be elucidated. Here, we report that LIX1 is S-palmitoylated on cysteine 84 and localized in mitochondria. LIX1 knock-down affects the mitochondrial ultrastructure, resulting in decreased respiration and mitochondrial reactive oxygen species production. This is sufficient to downregulate YAP1/TAZ and reprogram KIT-positive GIST cells towards the smooth muscle cell lineage with reduced proliferative and invasive capacities. Mechanistically, LIX1 knock-down impairs the stability of the mitochondrial proteins PHB2 and OPA1 that are found in complexes with mitochondrial-specific phospholipids and are required for cristae organization. Supplementation with unsaturated fatty acids counteracts the effects of LIX1 knock-down on mitochondrial morphology and ultrastructure, restores YAP1/TAZ signaling, and consequently KIT levels. Altogether, our findings demonstrate that LIX1 contributes to GIST aggressive potential by modulating YAP1/TAZ and KIT levels, a process that depends on mitochondrial remodeling. Our work brings new insights into the mechanisms that could be targeted in tumors in which YAP1 and TAZ are implicated.

cancer biology↗